Cargando…

Neuropeptide Receptors: Novel Targets for HIV/AIDS Therapeutics

The vasoactive intestinal peptide/pituitary adenylyl cyclase-activating polypepetide (VPAC) receptors are important for many physiologic functions, including glucose homeostasis, neuroprotection, memory, gut function, modulation of the immune system and circadian function. In addition, VPAC receptor...

Descripción completa

Detalles Bibliográficos
Autor principal:	Branch, Donald R.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2011
Materias:	Opinion
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4053798/ http://dx.doi.org/10.3390/ph4030485

Ejemplares similares

Pumping iron: a potential target for novel therapeutics against schistosomes
por: Glanfield, Amber, et al.
Publicado: (2007)

Dopaminergic Receptor Targeting in Multiple Sclerosis: Is There Therapeutic Potential?
por: Melnikov, Mikhail, et al.
Publicado: (2021)

Neuropeptide S Receptor as an Innovative Therapeutic Target for Parkinson Disease
por: Holanda, Victor A. D., et al.
Publicado: (2021)

Targeting the metabolism of leukemia stem cells as a novel therapeutic strategy
por: Ho, Emmanuel A, et al.
Publicado: (2013)

Vpu Matchmakers as a Therapeutic Strategy for HIV Infection
por: Montal, Mauricio
Publicado: (2009)

Therapeutics through glycobiology: an approach for targeted elimination of malaria
por: Divya, Mallya, et al.
Publicado: (2023)

Thirty years on: HIV receptor gymnastics and the prevention of infection
por: Weiss, Robin A
Publicado: (2013)

Decolonising humanitarianism or humanitarian aid?
por: Aloudat, Tammam, et al.
Publicado: (2022)

Contribution of HIV/AIDS-Related Human and Social Sciences Research to a Better Understanding of the Challenges of Hepatitis B Prevention, Diagnosis and Care
por: Bauquier, Charlotte, et al.
Publicado: (2021)

Glucocorticoid Receptor Signaling in NSCLC: Mechanistic Aspects and Therapeutic Perspectives
por: Papavassiliou, Kostas A., et al.
Publicado: (2023)

Equalizing the response to AIDS and other pandemics
por: Byanyima, Winnie, et al.
Publicado: (2022)

What if HIV were unable to develop resistance against a new therapeutic agent?
por: Wainberg, Mark A, et al.
Publicado: (2013)

Protein kinase Cα: disease regulator and therapeutic target
por: Konopatskaya, Olga, et al.
Publicado: (2010)

Q&A: targeting autophagy in cancer—a new therapeutic?
por: White, Eileen
Publicado: (2014)

Therapeutic potential of neuropeptide Y (NPY) receptor ligands
por: Brothers, Shaun P, et al.
Publicado: (2010)

African voices and leadership is imperative for the global AIDS response
por: Mbopi-Keou, Francois-Xavier, et al.
Publicado: (2019)

Roll Back Malaria? The scarcity of international aid for malaria control
por: Narasimhan, Vasant, et al.
Publicado: (2003)

Novel Mechanistic Insights into Viral Modulation of Immune Receptor Signaling
por: Sigalov, Alexander B.
Publicado: (2009)

Implications of the obesity epidemic for lipid-lowering therapy: Non-HDL cholesterol should replace LDL cholesterol as the primary therapeutic target
por: Hoenig, Michel R
Publicado: (2008)

Current perspectives on paediatric HIV management from the Mexico International Aids Society Conference, 2019
por: Archary, Mohendran, et al.
Publicado: (2019)

Targeting the right interventions to the right people and places: the role of geospatial analysis in HIV program planning
por: Meyer-Rath, Gesine, et al.
Publicado: (2018)

Plasma Phospho-Tau-181 as a Diagnostic Aid in Alzheimer’s Disease
por: Tsantzali, Ioanna, et al.
Publicado: (2022)

Neuropeptide S- and Neuropeptide S receptor-expressing neuron populations in the human pons
por: Adori, Csaba, et al.
Publicado: (2015)

Companion canines: an under-utilised model to aid in translating anti-metastatics to the clinic
por: van der Weyden, Louise, et al.
Publicado: (2019)

Risk of Increasing the Sudden Diagnosis of AIDS in Japan during and after the COVID-19 Outbreak
por: Jimba, Masamine, et al.
Publicado: (2021)

Use of DAMPs and SAMPs as Therapeutic Targets or Therapeutics: A Note of Caution
por: Land, Walter Gottlieb
Publicado: (2020)

Identification of neuropeptides and neuropeptide receptor genes in Phauda flammans (Walker)
por: Wu, Hai-Pan, et al.
Publicado: (2022)

The Cat and Mouse of HIV-1 Antibody Escape
por: Mascola, John R.
Publicado: (2009)

A Potential Target for Clinical Atherosclerosis: A Novel Insight Derived from TPM2
por: Meng, Ling-bing, et al.
Publicado: (2022)

Human Ebola virus infection in West Africa: a review of available therapeutic agents that target different steps of the life cycle of Ebola virus
por: Lai, Kang Yiu, et al.
Publicado: (2014)

Effectiveness of 4-1BB-costimulated HER2-targeted chimeric antigen receptor T cell therapy for synovial sarcoma
por: Murayama, Yudai, et al.
Publicado: (2021)

Proposal of “cyclic therapy”, a novel treatment strategy with targeted agents for advanced renal cell carcinoma
por: Nozawa, Masahiro, et al.
Publicado: (2013)

HIV Vaccine Development in the Aftermath of the STEP Study: Re-Focus on Occult HIV Infection?
por: Überla, Klaus
Publicado: (2008)

Molecular Evolution of the Neuropeptide S Receptor
por: Pitti, Thejkiran, et al.
Publicado: (2012)

The contrasting cultures of HIV and tuberculosis care
por: Daftary, Amrita, et al.
Publicado: (2015)

HIV control: Is getting there the same as staying there?
por: Goulder, Philip, et al.
Publicado: (2018)

The future of computer-aided sperm analysis
por: Mortimer, Sharon T, et al.
Publicado: (2015)

Psychological Aid for Frontline Healthcare Workers
por: Gloster, Andrew T., et al.
Publicado: (2020)

Complement Factors in COVID-19 Therapeutics and Vaccines
por: Kurtovic, Liriye, et al.
Publicado: (2021)

Corticotropin-Releasing Hormone: Biology and Therapeutic Opportunities
por: Caruso, Alessandra, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_fsqou7elkpnf36ql5f0mbqdua0